NMR-based Approaches for the Identification and Optimization of Inhibitors of Protein-protein Interactions

Overview

Journal Chem Rev

Publisher American Chemical Society

Specialty Chemistry

Date 2014 Apr 10

PMID 24712885

Citations 45

Authors

Elisa Barile

Maurizio Pellecchia

Affiliations

Soon will be listed here.

Citing Articles

Expanding the Functions of KHSRP Protein: Insights into DNA G-Quadruplex Binding.

Russomanno P, Zizza P, Cerofolini L, DAria F, Iachettini S, Di Vito S Adv Sci (Weinh). 2025; 12(8):e2410086.

PMID: 39763191 PMC: 11848572. DOI: 10.1002/advs.202410086.

Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 Mimetics.

Alboreggia G, Udompholkul P, Atienza E, Muzzarelli K, Assar Z, Pellecchia M J Med Chem. 2024; 67(22):20214-20223.

PMID: 39532346 PMC: 11613628. DOI: 10.1021/acs.jmedchem.4c01541.

Rapid Protein-Ligand Affinity Determination by Photoinduced Hyperpolarized NMR.

Butikofer M, Stadler G, Kadavath H, Cadalbert R, Torres F, Riek R J Am Chem Soc. 2024; 146(26):17974-17985.

PMID: 38957136 PMC: 11228983. DOI: 10.1021/jacs.4c04000.

Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1.

Alboreggia G, Udompholkul P, Baggio C, Muzzarelli K, Assar Z, Pellecchia M J Med Chem. 2024; 67(10):8172-8185.

PMID: 38695666 PMC: 11129181. DOI: 10.1021/acs.jmedchem.4c00277.

Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1.

Alboreggia G, Udompholkul P, Baggio C, Pellecchia M J Med Chem. 2023; 66(14):10108-10118.

PMID: 37464766 PMC: 10388297. DOI: 10.1021/acs.jmedchem.3c01073.

References

Jahnke W, Rudisser S, Zurini M . Spin label enhanced NMR screening. J Am Chem Soc. 2001; 123(13):3149-50. DOI: 10.1021/ja005836g. View

Becattini B, Sareth S, Zhai D, Crowell K, Leone M, Reed J . Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. Chem Biol. 2004; 11(8):1107-17. DOI: 10.1016/j.chembiol.2004.05.022. View

McGovern S, Helfand B, Feng B, Shoichet B . A specific mechanism of nonspecific inhibition. J Med Chem. 2003; 46(20):4265-72. DOI: 10.1021/jm030266r. View

Dalvit C, Fasolini M, Flocco M, Knapp S, Pevarello P, Veronesi M . NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands. J Med Chem. 2002; 45(12):2610-4. DOI: 10.1021/jm011122k. View

Ferguson F, Fedorov O, Chaikuad A, Philpott M, Muniz J, Felletar I . Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain. J Med Chem. 2013; 56(24):10183-7. PMC: 3905694. DOI: 10.1021/jm401582c. View

Raimundo B, Oslob J, Braisted A, Hyde J, McDowell R, Randal M . Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions. J Med Chem. 2004; 47(12):3111-30. DOI: 10.1021/jm049967u. View

Oltersdorf T, Elmore S, Shoemaker A, Armstrong R, Augeri D, Belli B . An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005; 435(7042):677-81. DOI: 10.1038/nature03579. View

Sykes B . Determination of the conformations of bound peptides using NMR-transferred nOe techniques. Curr Opin Biotechnol. 1993; 4(4):392-6. DOI: 10.1016/0958-1669(93)90003-f. View

Betz M, Saxena K, Schwalbe H . Biomolecular NMR: a chaperone to drug discovery. Curr Opin Chem Biol. 2006; 10(3):219-25. PMC: 7185745. DOI: 10.1016/j.cbpa.2006.04.006. View

10.

Baell J, Holloway G . New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010; 53(7):2719-40. DOI: 10.1021/jm901137j. View

11.

Billeter M, Wagner G, Wuthrich K . Solution NMR structure determination of proteins revisited. J Biomol NMR. 2008; 42(3):155-8. PMC: 2748914. DOI: 10.1007/s10858-008-9277-8. View

12.

Pellecchia M, Meininger D, Dong Q, Chang E, Jack R, Sem D . NMR-based structural characterization of large protein-ligand interactions. J Biomol NMR. 2002; 22(2):165-73. DOI: 10.1023/a:1014256707875. View

13.

Lepre C, Peng J, Fejzo J, Abdul-Manan N, Pocas J, Jacobs M . Applications of SHAPES screening in drug discovery. Comb Chem High Throughput Screen. 2002; 5(8):583-90. DOI: 10.2174/1386207023329950. View

14.

Valkov E, Sharpe T, Marsh M, Greive S, Hyvonen M . Targeting protein-protein interactions and fragment-based drug discovery. Top Curr Chem. 2011; 317:145-79. DOI: 10.1007/128_2011_265. View

15.

Wells J, McClendon C . Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature. 2007; 450(7172):1001-9. DOI: 10.1038/nature06526. View

16.

Pinilla C, Appel J, Blondelle S, Dooley C, Dorner B, Eichler J . A review of the utility of soluble peptide combinatorial libraries. Biopolymers. 1995; 37(3):221-40. DOI: 10.1002/bip.360370306. View

17.

Seidler J, McGovern S, Doman T, Shoichet B . Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem. 2003; 46(21):4477-86. DOI: 10.1021/jm030191r. View

18.

Frostell A, Vinterback L, Sjobom H . Protein-Ligand Interactions Using SPR Systems. Methods Mol Biol. 2013; 1008:139-65. DOI: 10.1007/978-1-62703-398-5_6. View

19.

Clark M, Meshkat S, Talbot G, Carnevali P, Wiseman J . Fragment-based computation of binding free energies by systematic sampling. J Chem Inf Model. 2009; 49(8):1901-13. DOI: 10.1021/ci900132r. View

20.

Houghten R, Pinilla C, Giulianotti M, Appel J, Dooley C, Nefzi A . Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J Comb Chem. 2007; 10(1):3-19. DOI: 10.1021/cc7001205. View